Repository logo
 
Publication

Varenicline suicidal ideation in psychiatric patients − a case report and systematic review

dc.contributor.authorRodrigues, Carina
dc.contributor.authorAndrade, M.
dc.contributor.authorBettencourt, Mariana Mendonça
dc.contributor.authorPalma, V.
dc.contributor.authorCardoso, C.
dc.date.accessioned2024-06-06T13:26:22Z
dc.date.available2024-06-06T13:26:22Z
dc.date.issued2016
dc.description.abstractVarenicline, a partial agonist selective for a4b2 nicotinic acetylcholine receptor subtypes, was approved in 2006 by the FDA as an aid for smoking cessation in association to counselling. Since its commercialization, many individual cases reported psychiatric adverse effects on patients prescribed with varenicline− such as depressive mood, anxiety, suicidal ideation or even suicidal attempt. Subsequently, the FDA required the addition of a Boxed Warning to this drug. It is believed this reports leaded to some apprehension on its prescription [1].pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationRodrigues, Carina.; Andrade, M.; Bettencourt, M.; Palma, V.; Cardoso, C. (2016). Varenicline suicidal ideation in psychiatric patients − a case report and systematic review. European Neuropsychopharmacology. ISSN 0924-977X. 26, S710-S710pt_PT
dc.identifier.doi10.1016/S0924-977X(16)31849-1pt_PT
dc.identifier.eissn1873-7862
dc.identifier.issn0924-977X
dc.identifier.urihttp://hdl.handle.net/10198/29870
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.titleVarenicline suicidal ideation in psychiatric patients − a case report and systematic reviewpt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.endPageS710pt_PT
oaire.citation.startPageS710pt_PT
oaire.citation.titleEuropean Neuropsychopharmacologypt_PT
oaire.citation.volume26pt_PT
person.familyNameRodrigues
person.givenNameCarina
person.identifier.ciencia-idC415-C677-0253
person.identifier.orcid0000-0001-9773-1413
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isAuthorOfPublicationef666665-6593-48be-bc48-6a1bb58bedbd
relation.isAuthorOfPublication.latestForDiscoveryef666665-6593-48be-bc48-6a1bb58bedbd

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1_s2.0_S0924977X16318491_main.pdf
Size:
53.77 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: